v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net income attributable to The Vita Coco Company, Inc. $ 30,474 $ 18,882  
Adjustments required to reconcile net income to cash flows from operating activities:      
Depreciation and amortization 476 202  
Amortization of debt issuance cost 5 0  
(Decrease) increase of provision for credit losses (384) 434  
Unrealized gain on derivative instruments (2,827) (2,817)  
Stock-based compensation 4,626 2,186  
Noncash lease expense 633 504  
Changes in operating assets and liabilities:      
Accounts receivable (39,444) (13,150)  
Inventory 24,815 (4,508)  
Prepaid expenses, net supplier advances, and other assets (6,536) (2,583)  
Accounts payable, accrued expenses, and other liabilities 3,762 (8,950)  
Net cash provided by (used in) operating activities 15,600 (9,800)  
Cash flows from investing activities:      
Cash paid for property and equipment (461) (559)  
Net cash used in investing activities (461) (559)  
Cash flows from financing activities:      
Proceeds from exercise of stock awards 1,606 404  
Cash paid on notes payable (3) (2)  
Cash paid to acquire treasury stock (11,505) (1,501) $ (11,269)
Net cash used in financing activities (9,902) (1,099)  
Effects of exchange rate changes on cash and cash equivalents (195) 401  
Net increase (decrease) in cash and cash equivalents 5,042 (11,057)  
Cash, cash equivalents and restricted cash at beginning of the period [1] 198,154 165,933 165,933
Cash, cash equivalents and restricted cash at end of period [1] $ 203,196 $ 154,876 $ 198,154
[1] Includes $1,281 and $1,264 of restricted cash as of December 31, 2025 and 2024, respectively. Includes $1,284 and $1,268 of restricted cash as of March 31, 2026 and 2025, respectively, reported in other current assets on the condensed consolidated balance sheet.